MARKET

CASI

CASI

CASI Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.950
+0.080
+4.28%
Opening 12:36 04/02 EDT
OPEN
1.870
PREV CLOSE
1.870
HIGH
1.980
LOW
1.820
VOLUME
35.02K
TURNOVER
--
52 WEEK HIGH
3.820
52 WEEK LOW
1.150
MARKET CAP
193.10M
P/E (TTM)
-4.0659
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CASI stock price target is 3.500 with a high estimate of 3.500 and a low estimate of 3.500.

EPS

CASI News

More
  • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analysts Just Slashed This Year's Estimates
  • Simply Wall St. · 2d ago
  • Daily Insider Ratings Round Up 3/27/20
  • Seeking Alpha - Article · 3d ago
  • Insider Buying: The CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Chairman & CEO Just Bought US$1.1m Worth Of Shares
  • Simply Wall St. · 4d ago
  • Daily Insider Ratings Round Up 3/19/20
  • Seeking Alpha - Article · 03/20 20:34

Industry

Biotechnology & Medical Research
+1.99%
Pharmaceuticals & Medical Research
+1.59%

Hot Stocks

Symbol
Price
%Change

About CASI

CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. It operates through the development of targeted therapeutics for the treatment of cancer segment. Its product pipeline includes internal development of its lead drug candidate, ENMD-2076; MARQIBO, ZEVALIN and EVOMELA, and early-stage candidates in preclinical development. Its ENMD-2076 is an orally active, Aurora A/angiogenic kinase inhibitor with a kinase selectivity profile and multiple mechanisms of action. Its Marqibo is a sphingomyelin/cholesterol liposome-encapsulated, formulation of vincristine sulfate. Its ZEVALIN (ibritumomab tiuxetan) injection for intravenous use is a CD20-directed radiotherapeutic antibody. Its EVOMELA is an intravenous formulation of melphalan being investigated by Spectrum in the multiple myeloma transplant setting. Its pipeline also includes 2ME2 (2-methoxyestradial).
More

Webull offers kinds of CASI Pharmaceuticals Inc stock information, including NASDAQ:CASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CASI stock news, and many more online research tools to help you make informed decisions.